{"id":47526,"date":"2026-02-26T12:38:49","date_gmt":"2026-02-26T07:08:49","guid":{"rendered":"https:\/\/dailynewsindia.co.in\/index.php\/2026\/02\/26\/infomerics-upgrade-fredun-pharmaceuticals-credit-rating-to-bbb-plus-boosts-financial-profile\/"},"modified":"2026-02-26T12:38:49","modified_gmt":"2026-02-26T07:08:49","slug":"infomerics-upgrade-fredun-pharmaceuticals-credit-rating-to-bbb-plus-boosts-financial-profile","status":"publish","type":"post","link":"https:\/\/dailynewsindia.co.in\/index.php\/2026\/02\/26\/infomerics-upgrade-fredun-pharmaceuticals-credit-rating-to-bbb-plus-boosts-financial-profile\/","title":{"rendered":"Infomerics Upgrade Fredun Pharmaceuticals Credit Rating to BBB Plus; Boosts Financial Profile"},"content":{"rendered":"
\n

Mumbai (Maharashtra) [India], February 26:<\/strong> <\/span>Fredun Pharmaceuticals Limited (BSE \u2013 FREDUN | 539730), is one of the Leading Pharmaceuticals Formulation manufacturing companies in India. Diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility, and animal healthcare products, has secured a credit rating upgrade from Infomerics Valuation and Rating Limited for its bank facilities aggregating to \u20b9156.17 crore.<\/p>\n

Infomerics\u00a0has upgraded the Company\u2019s long-term bank facilities to\u00a0IVR BBB+ with Stable Outlook\u00a0from IVR BBB with Stable Outlook, while reaffirming the short-term rating at\u00a0IVR A2.\u00a0Earlier, the company received a similar upgrade from Brickwork, raising its bank facility credit rating from A3+ to A2.<\/p>\n

A Clear Validation of Strengthening Fundamentals<\/strong><\/p>\n

The rating upgrade is a significant milestone that reflects\u00a0FredunPharmaceuticals\u00a0improved operational performance, stronger financial profile, and disciplined capital management across FY24 and FY25 (Audited).<\/p>\n

The total bank facilities rated comprise:<\/strong><\/p>\n

\u2022\u00a0\u20b9143.17 crore \u2013 Long-Term Bank Facilities<\/p>\n

\u2022\u00a0\u20b913.00 crore \u2013 Long-Term\/Short-Term Working Capital Facilities<\/p>\n

The upgraded IVR BBB+ rating indicates an enhanced degree of safety regarding the timely servicing of financial obligations and demonstrates improving credit quality. The Stable outlook further signifies the rating agency\u2019s confidence in the Company\u2019s ability to sustain its performance trajectory and maintain a balanced financial risk profile.<\/p>\n

Strategic Significance of the Upgrade<\/strong><\/p>\n

This development goes beyond a routine rating review. It represents:<\/p>\n

\u2022\u00a0Strengthened banking confidence and institutional credibility<\/p>\n

\u2022\u00a0Improved financial flexibility to support expansion initiatives<\/p>\n

\u2022\u00a0Potential optimization of borrowing costs<\/p>\n

\u2022\u00a0Enhanced positioning for future growth capital requirements<\/p>\n

As Fredun Pharmaceuticals continues to expand its export presence across Africa, Southeast Asia, CIS countries, and Latin America, the upgraded credit rating strengthens its financial flexibility to efficiently manage working capital and support strategic growth initiatives.<\/p>\n

The upgrade reflects the Company\u2019s consistent revenue momentum, operational efficiency, and prudent leverage management, reinforcing its commitment to building a resilient, scalable, and globally competitive pharmaceutical platform.<\/p>\n

Commenting on the update, Mr. Fredun Medhora, Managing Director, said, \u201cThis upgrade is encouraging for all of us at Fredun. It reflects the hard work of our team and the disciplined manner in which we are building the business. As we continue to grow across markets, our focus remains on strengthening the Company\u2019s foundation while pursuing larger opportunities responsibly.\u201d<\/p>\n

Disclaimer<\/strong>: This article is for informational purposes only and does not constitute financial advice.<\/span><\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Mumbai (Maharashtra) [India], February 26: Fredun Pharmaceuticals Limited (BSE \u2013 FREDUN | 539730), is one of the Leading Pharmaceuticals Formulation manufacturing companies in India. Diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility, and animal healthcare products, has secured a credit rating upgrade from Infomerics Valuation and Rating Limited for its bank facilities aggregating to \u20b9156.17 crore. Infomerics\u00a0has…<\/p>\n

Read More “Infomerics Upgrade Fredun Pharmaceuticals Credit Rating to BBB Plus; Boosts Financial Profile”<\/span> »<\/a><\/p>\n","protected":false},"author":1,"featured_media":47527,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[54],"class_list":["post-47526","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-business"],"_links":{"self":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts\/47526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/comments?post=47526"}],"version-history":[{"count":0,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts\/47526\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/media\/47527"}],"wp:attachment":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/media?parent=47526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/categories?post=47526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/tags?post=47526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}